Clinical Usefulness of Implanted Fiducial Markers for Hypofractionated Radiotherapy of Prostate Cancer
![]() |
Choi, Young-Min
(Department of Radiation Oncology, Dong-A University School of Medicine)
Ahn, Sung-Hwan (Department of Radiation Oncology, Dong-A University School of Medicine) Lee, Hyung-Sik (Department of Radiation Oncology, Dong-A University School of Medicine) Hur, Won-Joo (Department of Radiation Oncology, Dong-A University School of Medicine) Yoon, Jin-Han (Department of Urology, Dong-A University School of Medicine) Kim, Tae-Hyo (Department of Urology, Dong-A University School of Medicine) Kim, Soo-Dong (Department of Urology, Dong-A University School of Medicine) Yun, Seong-Guk (Department of Radiology, Dong-A University School of Medicine) |
1 | Ogino I, Uemura H, Inoue T, Kubota Y, Nomura K, Okamoto N. Reduction of prostate motion by removal of gas in rectum during radiotherapy. Int J Radiat Oncol Biol Phys 2008;72:456-466 DOI ScienceOn |
2 | van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1121-1135 DOI ScienceOn |
3 | Melancon AD, O'Daniel JC, Zhang L, et al. Is a 3-mm intrafractional margin sufficient for daily image-guided intensitymodulated radiation therapy of prostate cancer? Radiother Oncol 2007;85:251-259 DOI ScienceOn |
4 | Li HS, Chetty IJ, Enke CA, et al. Dosimetric consequences of intrafraction prostate motion. Int J Radiat Oncol Biol Phys 2008;71:801-812 DOI ScienceOn |
5 | Ghilezan MJ, Jaffray DA, Siewerdsen JH, et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005;62:406-417 DOI ScienceOn |
6 | Roeske JC, Forman JD, Mesina CF, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:1321-1329 DOI ScienceOn |
7 | van Herk M, Bruce A, Kroes AP, Shouman T, Touw A, Lebesque JV. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 1995;33:1311-1320 DOI ScienceOn |
8 | Beard CJ, Kijewski P, Bussiere M, et al. Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int J Radiat Oncol Biol Phys 1996;34:451-458 DOI ScienceOn |
9 | Fiorino C, Di Muzio N, Broggi S, et al. Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy. Int J Radiat Oncol Biol Phys 2008;71:611-617 DOI ScienceOn |
10 | Nijkamp J, Pos FJ, Nuver TT, et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys 2008;70:75-82 DOI ScienceOn |
11 | Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999;43:1095-1101 DOI ScienceOn |
12 | Heemsbergen WD, Hoogeman MS, Witte MG, Peeters ST, Incrocci L, Lebesque JV. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy. Int J Radiat Oncol Biol Phys 2007;67:1418-1424 DOI ScienceOn |
13 | Watchman CJ, Hamilton RJ, Stea B, Mignault AJ. Patient positioning using implanted gold markers with the Novalis Body system in the thoracic spine. Neurosurgery 2008;62(5 Suppl):A62-A68 DOI |
14 | Soete G, De Cock M, Verellen D, Michielsen D, Keuppens F, Storme G. X-ray-assisted positioning of patients treated by conformal arc radiotherapy for prostate cancer: comparison of setup accuracy using implanted markers versus bony structures. Int J Radiat Oncol Biol Phys 2007;67:823-827 DOI ScienceOn |
15 | Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635-642 DOI ScienceOn |
16 | Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002;52:6-13 DOI ScienceOn |
17 | Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294:1233-1239 DOI ScienceOn |
18 | Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097-1105 DOI ScienceOn |
19 | Huang EH, Pollack A, Levy L, et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54:1314-1321 DOI ScienceOn |
20 | de Crevoisier R, Tucker SL, Dong L, et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:965-973 DOI ScienceOn |
21 | Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:491-500 DOI ScienceOn |
![]() |